Preliminary Surface View
TruGrit: DiPALS & RespiStimALS - Google Drive

This chart abstracts the losses during the DiPALS and RespiStimALS clinical trials.

The losing cohort in each temporal period is denoted in red; note the DiPALS control cohort is the only cohort with two losses; the DiPALS treatment cohort lost only once, . . . both of RespiStimALS cohorts are surgical cohorts but they incurred no loss temporal periods. In fact the RespiStimALS early stim cohort clearly outperformed the DiPALS NiV cohort (56 to 49 moons) and the sham RespiStimALS cohort might have if their effort was not curtailed by the possible problem DiPALS encountered.

Definitely a poor choice of emotocon if that is the one I picked, sorry. I am trying to show the data shows fewer deaths were occurring per time period in almost all of the time periods of the study when compared to the NiV cohort; with only one major exception . . . raises the possibility of statistical anomaly or even sabotage (remember, these studies are typically blinded but the DiPALS was open label (not blinded).
pacing patients in